Blog
RSS FeedPosted by Michael Wonder on 03 Dec 2023
Agenda for the December 2023 PBAC intracycle meeting
1 December 2023 - The agenda for the December 2023 PBAC intracycle meeting is now available. ...
Posted by Michael Wonder on 02 Dec 2023
FDA grants priority review to Merck’s application for Keytruda (pembrolizumab) plus Padcev (enfortumab vedotin-ejfv) for the first-line treatment of patients with locally advanced or metastatic urothelial cancer
30 November 2023 - Acceptance based on results from the Phase 3 KEYNOTE-A39 trial, which showed a statistically significant and ...
Posted by Michael Wonder on 02 Dec 2023
Keytruda is a step closer to being available for more cancers listed on the PBS
1 December 2023 - Thousands of cancer patients in Australia will benefit from a major change that would see Keytruda offered ...
Posted by Michael Wonder on 02 Dec 2023
Updates to the HTA Policy and Methods Review Reference Committee (1 December 2023)
1 December 2023 - To ensure that the Reference Committee has sufficient time to consider the extensive and valuable input ...
Posted by Michael Wonder on 01 Dec 2023
New frontier will lead to better health outcomes
30 November 2023 - The Government has today tabled its response to an inquiry considering how to give Australian patients timely ...
Posted by Michael Wonder on 30 Nov 2023
Schedule of Pharmaceutical Benefits - 1 December 2023
1 December 2023 - The December 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 27 Nov 2023
Cheaper medicines and more bulk billing
27 November 2023 - Australians are on track to save a quarter of a billion dollars on their medicines in 2023, ...
Posted by Michael Wonder on 22 Nov 2023
MSAC publishes agenda for April MSAC meeting
22 November 2023 - The MSAC Secretariat has published a list of applications scheduled to be considered by the MSAC on ...
Posted by Michael Wonder on 22 Nov 2023
Agenda for the March 2024 PBAC meeting
22 November 2023 - The agenda for the March 2024 PBAC meeting is now available. ...
Posted by Michael Wonder on 22 Nov 2023
ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines
20 November 2023 - Recommendations from the Australian Technical Advisory Group on Immunisation on the use of XBB 1.5 COVID-19 vaccines. ...
Posted by Michael Wonder on 22 Nov 2023
Updates to the HTA Review Research and Analysis papers collection: draft HTA expert paper published
22 November 2023 - The draft paper 'Optimising the availability and use of real world data and real world evidence to ...
Posted by Michael Wonder on 21 Nov 2023
Funding verdict looms on ‘future of cancer therapy’
21 November 2023 - The chance of survival for hundreds of Australians living with a deadly type of blood cancer ...
Posted by Michael Wonder on 20 Nov 2023
New Covid-19 vaccines available to target current variants
20 November 2023 - The Australian Government has accepted the latest advice from the Australian Technical Advisory Group on Immunisation on ...
Posted by Michael Wonder on 16 Nov 2023
Updates to the HTA Policy and Methods Review Reference Committee (16 November 2023)
16 November 2023 - Two more documents are now available. ...
Posted by Michael Wonder on 16 Nov 2023
New treatment for advanced prostate cancer added to the PBS
16 November 2023 - Prostate cancer is one of the most commonly diagnosed cancer in Australia. ...